Max Byerly

LON:DSCV – Get Free Report ) rose 1.7% on Friday . The stock traded as high as GBX 792 and last traded at GBX 790. 2,139,371 shares traded hands during trading, an increase of 105% from the average daily volume of 1,046,095 shares. The stock had previously closed at GBX 777.

OTCMKTS:YDUQY – Get Free Report )'s stock price shot up 15.9% during mid-day trading on Friday . The stock traded as high as $1.4950 and last traded at $1.4950. 1,400 shares changed hands during trading, a decline of 78% from the average session volume of 6,393 shares. The stock had previously closed at $1.29.

LON:TTE – Get Free Report )'s stock price was up 1% on Friday . The company traded as high as GBX 78.77 and last traded at GBX 78.30. 4,304,042 shares changed hands during trading, an increase of 86% from the average daily volume of 2,308,028 shares. The stock had previously closed at GBX 77.50.

TSE:ENB.PH – Get Free Report ) shares were down 0.7% on Friday . The company traded as low as C$24.34 and last traded at C$24.34. Approximately 1,148 shares traded hands during mid-day trading, The stock had previously closed at C$24.50.

Jefferies Financial Group restated their buy rating on shares of in a report issued on Wednesday,Digital Look reports. The brokerage currently has a GBX 488 price target on the stock

NYSE:FUL – Get Free Report ) has been assigned a consensus rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, three have issued a buy rating and two have assigned a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $67.8571.

UBS Group assumed coverage on shares of Tempus AI ( – Free Report in a report published on Wednesday, Marketbeat.com reports. The firm issued a neutral rating and a $70.00 price target on the stock

BWS Financial initiated coverage on shares of Twist Bioscience ( – Free Report in a research report released on Wednesday morning, Marketbeat.com reports. The brokerage issued a sell rating and a $45.00 target price on the stock

UBS Group began coverage on shares of Mettler-Toledo International ( – Free Report in a research note published on Wednesday morning, Marketbeat.com reports. The brokerage issued a neutral rating and a $1,460.00 price target on the medical instruments supplier's stock

NASDAQ:FRSH – Get Free Report ) has been given a consensus recommendation of “Moderate Buy” by the sixteen research firms that are presently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $14.1667.